| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |